Decitabine/Tetrahydrouridine (EpiDestiny/Novo Nordisk) | Interleukin Related interleukin-related.com

Product Name :
Decitabine/Tetrahydrouridine (EpiDestiny/Novo Nordisk)

Search keywords :
Tetrahydrouridine

drugId :
null

Target Vo:
Cytidine deaminase

Target Vo Short Name :
CDA

Moa_Name:
Cytidine deaminase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Epicdestiny

Active Company_Name :
Epidestiny Inc

Active Indication_Name:
Anemia, Sickle Cell

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MAPK14 Antibody
S100A4 Antibody
Mitofusin 1 Antibody: Mitofusin 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to Mitofusin 1. It can be used for WB,IP assays with tag free, in the background of Mouse, Rat, Hamster.

Author: Interleukin Related

Related Posts